November 15, 1994 |
A week after restricting a major drug industry merger, the Federal Trade Commission is examining another--SmithKline Beecham's purchase of Diversified Pharmaceutical Services Inc. London-based SmithKline Beecham said Monday that it was not surprised by the FTC's notice, but it added that it worked closely with the agency before finalizing its $2.3-billion deal last May. Diversified, of Bloomington, Minn., manages prescription drug benefits for 11 million people in the United States.
July 26, 1989 |
SmithKline Beckman Corp. said its shareholders today approved the company's merger with Beecham Group PLC., creating the world's second largest pharmaceuticals group. SmithKline said the stock-swap merger took effect in the morning after regulatory filings in Pennsylvania and London. SmithKline said the merger was approved by about 99% of the shares voted at today's special meeting. Beecham stockholders previously approved the deal, worth about $7.7 billion. SmithKline's stock was up 62.